Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses | MicrobiomeTrials← Back to trialsNCT07631598
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-10Est. Completion: 2028-02
Enrollment target: 512 participants Locations- Community Health Project Los Angeles (CHPLA), Los Angeles, California, United States
- HIPS, Washington D.C., District of Columbia, United States
- CARPBR/Be Safe Syringe Program, Baton Rouge, Louisiana, United States
- Harm Reduction Sisters, Duluth, Minnesota, United States
- Alianza of New Mexico, Roswell, New Mexico, United States
- HIV Alliance, Grants Pass, Oregon, United States
- Challenges, Inc/Prisma Health, Greenville, South Carolina, United States
- Vivent Health, Milwaukee, Wisconsin, United States
Other microbiome trials you might be interested in
Analgesics, OpioidAcute PainTooth ExtractionAdolescentAcetaminophenIbuprofen
The goal of this clinical trial is to test a three-item intervention in oral surgeons who remove teeth. The main questio…
Lexington, United StatesCompleted Jan 2028
Hindfoot SurgeryAnalgesiaPerineural Catheter
Postoperative pain following hindfoot surgery is often severe and can persist for several days. It frequently leads to t…
Angers, FranceEst. completion Feb 7, 2027
HIV InfectionsDrug UseOpioid UseOpioid-use Disorder
The purpose of this study is to determine the efficacy of using a mobile health delivery unit ("mobile unit") to deliver…
Los Angeles, United StatesCompleted Dec 17, 2024